- Open Access
Taking promoters out of enhancers in sequence based predictions of tissue-specific mammalian enhancers
© The Author(s) 2017
Published: 24 May 2017
Many genetic diseases are caused by mutations in non-coding regions of the genome. These mutations are frequently found in enhancer sequences, causing disruption to the regulatory program of the cell. Enhancers are short regulatory sequences in the non-coding part of the genome that are essential for the proper regulation of transcription. While the experimental methods for identification of such sequences are improving every year, our understanding of the rules behind the enhancer activity has not progressed much in the last decade. This is especially true in case of tissue-specific enhancers, where there are clear problems in predicting specificity of enhancer activity.
We show a random-forest based machine learning approach capable of matching the performance of the current state-of-the-art methods for enhancer prediction. Then we show that it is, similarly to other published methods, frequently cross-predicting enhancers as active in different tissues, making it less useful for predicting tissue specific activity. Then we proceed to show that the problem is related to the fact that the enhancer predicting models exhibit a bias towards predicting gene promoters as active enhancers. Then we show that using a two-step classifier can lead to lower cross-prediction between tissues.
We provide whole-genome predictions of human heart and brain enhancers obtained with two-step classifier.
Transcription regulation is a complex process requiring tight control at multiple steps including transcription initiation, elongation and splicing. In case of tissue specific genes in metazoan genomes, the control of the transcription initiation is performed largely by means of enhancers, i.e. distinct sequence elements, that allow for binding of transcription factor proteins, facilitating transcription . While the exact molecular mechanism of enhancer-promoter interaction remains a field of active study, we have now accumulated a large body of examples of enhancer sequences to ask whether we can make predictions regarding enhancer location in the genome based on sequence features. This is an important question, given the complexity of a gene regulation system in a multi-cellular organism such as humans composed of hundreds of cell types, each of which expresses thousands of genes, most of which are modulated with some cell-type specificity. Moreover, a typical cell-type-specific gene can be controlled by multiple enhancers. Adding it all up, in order to describe a tissue-specific gene regulation, we need to describe on the order of 100 thousands of regulator elements .
Mapping all these elements using experimental techniques is currently completely unfeasible, as many cell-types are too difficult to obtain in large quantities required for experimental assessment of enhancer activity. This leads to a situation, where we have hundreds of well documented examples of regulatory elements functional in a certain context (i.e. cell-type, developmental time) determined by a certain method (enhancer reporter assays , STARR-Seq , luciferase assays, in-situ hybridization etc). This, however, cannot easily be scaled up to the level of complete coverage of all cell types and all developmental time points. On the other hand, the data collected by the ENCODE or Epigenome Roadmap  are invaluable as a source for computational attempts at making models that would be predictive beyond the collected data and perhaps eventually help defining the principles of tissue-specific action of regulatory elements.
Even before the complete sequence of the human genome was known, people have been working on computational descriptions of enhancer sequences – mostly based on clusters of transcription factor binding sites [6, 7]. Later, these models were improved by including evolutionary conservation of sequence features  leading to a classical now approach of predicting enhancers as evolutionarily conserved clusters of transcription factor binding sites. While a number of methods following this theme, but varying greatly on the technical side [9–11] has been proposed in the first decade of 2000s, their relative performance was inherently limited by the imperfect training data [12, 13]. The limitations were not only due to the small training sets but also the difficulty to assess the true quality of predictions.
Importantly, while the databases containing the position weight matrices describing transcription factor binding specificity grew rapidly, it became clear that they are not necessarily the best representations of the important sequence features for enhancer predictions . This is due to two main reasons: large similarity of many transcription factor’s binding domains, leading to very similar DNA specificity and the frequently artificial specificity encoded in the position weight matrices based on context-specific determination of binding. Taking the two together, the sequence motif databases were not optimal for the task and it has been shown that the same or better accuracy in enhancer prediction can be achieved with counting k-mers, instead of the actual transcription factor motifs .
The advent of the ChIP-Seq technology , allowing researchers to directly assay transcription factor binding as well as multiple histone modifications, changed the situation. The availability of genome-wide measurements of transcription factor binding enabled much more comprehensive training of the predictors based on generic machine learning methods [17, 18], however they uncovered an unanticipated complexity of enhancer activity. In particular, the ChIP-Seq based methods allowed us to uncover many regulatory elements that were clearly functional without a detectable sequence conservation between species , and the studies of transcription factor binding across developmental time-points or conditions detected large scale context dependency of enhancer function . These findings were later corroborated by multiple studies using DNAse-Seq methods [20, 21].
The wide adoption of ChIP-Seq technique together with concentrated experimental efforts of ENCODE and similar allowed for the new wave of computational approaches to appear. Typically these would take advantage of hundreds genome-wide tracks of ChIP-Seq, DNAse-Seq and other information (such as mRNA-Seq or GRO-Seq) and use a state-of-the-art machine learning method such as SVM [22, 23], Bayesian Networks , random forests [24, 25], neural networks  or regression based, such as support vector regression  or logistic regression . The first study by Erwin et al. should be noted especially for their careful analysis of the specificity of the classifiers. They observed, that when they trained their models on positive vs. random data sets, the resulting classifiers gave overlapping predictions between tissues. Erwin et al. used a specific way of two-layer classification, where they first predicted whether a sequence is an enhancer and in the second step they actually predicted to which class from the training set it belongs. This is an important observation, however, the solution leaves room for improvement as it yields classifiers that are only capable of discerning between the activity classes known at the time of learning. In particular, using this approach one cannot make any claims regarding the overlap of predictions with the regions with activity in any other tissue.
It should be noted that many of these studies differ significantly also in their choice of the training sets. For example Zhu et al.  use eRNAs as their positive set, Danko et al.  utilize GRO-Seq data, Firpi et al.  use histone modification Chip signals preprocessed by Heintzmann et al.  while Rajagopal  uses p300 distal binding sites. All of these are then very difficult to compare with approaches such as ours or Erwin et al’s  that use Vista enhancers.
While enhancer predictions in these studies have reached the level of approximately 90 percent of AUC (Area under the ROC curve) in cross-validated setup, their ability to help us understand the function of enhancers is limited, partially because of their foundation on a very large set of measurements and somewhat opaque machine learning approaches. This has prompted us to approach this problem with a slightly different methodology. We have focused on the issue of enhancer tissue-specificity, i.e. the ability of enhancer sequences to be active only under a very defined set of circumstances and to define a set of features that are crucial for predicting the activity. This has led us to focus less on quality of predictions, but still above “acceptable” level of 80 percent AUC, while retaining the possibility of rigorously assessing the relative importance of the features used for prediction. This has lead to many interesting predictions that are very specific to heart or brain (See Additional file 1: Figure S8, S9 and S10 for representative examples).
In this work we report our findings based on applying Random Forest classification to the problem of enhancer prediction in the human genome. Based on our previous experiences with the Drosophila [24, 29], we have used histone modification ChIP-Seq datasets from ENCODE and the enhancer sequences from the Vista project. Using these data, we have defined a set of features that are relevant to define active enhancers and then we went to assess the tissue specificity of the prediction using the heart and brain tissue annotation from the Vista project. This has lead to our discovery that both groups share an enrichment for predictions in the group of proximal-promoter sequences leading to two kinds of problems: firstly both classifiers predict promoters as enhancer and secondly, both classifiers use shared features to predict promoter regions leading to further overlap in genome-wide predictions. In order to tackle this problem we proposed building two-layer classifier, where one layer is responsible for detecting tissue-specific enhancer signals while the other is a pure sequence-based filter of promoter-like sequences that ensures greater specificity of the complete classifier.
Training set and data preparation
Positive training set We downloaded all human sequences available in VISTA Enhancer Browser on April 15th, 2014. Our heart training set consists of sequences that show heart activity (among others) but no brain activity, and brain training set is defined as sequences with activity in at least one of those tissues: hindbrain, midbrain, forebrain, neural tube, cranial nerve, but does not show heart activity. Non-specific classifier is trained on both heart and brain sets, defined as above.
Negative training set Negative training sets were chosen randomly from the human genome hg19 in the way that they preserve chromosome and length distribution the same as in corresponding positive set. We draw lengths of sequences from Negative Binomial Distribution with parameters matching mean and variance of lengths of sequences in the positive training set. Since heart enhancers in VISTA database are on average longer than brain enhancers (see Additional file 1: Figure S3), we draw separate negative training sets for heart and brain classifiers. We ensure we do not include sequences with ambiguous bases and sequences that have less than 10% of signal in more than quarter of considered histone modifications tracks.
Sequence features Our sequence feature set consist of all possible k-mers – continuous sequences of k bases, excluding second alphabetically k-mer for each pair of reverse complement k-mers. Each feature is represented by number of occurrences of k-mer (or its reverse complement) over length of sequence. Since our random set is chosen in the way, that it doesn’t contain ambiguous bases, we have almost no such bases in the sequences so while counting we skip k-mers containing ‘N’.
Histone modifications features Histone modification signal was obtained from ChIP-Seq experiment results from ENCODE database. We used downloaded normalized signal for all histone modifications available for cells from Tier1 (H1hESC, GM12878, K562) and normal (non-cancer) cells from Tier2 (CD20+, CD20+_RO01778, CD20+_RO01794, HUVEC, Monocytes-CD14+_RO01746). For list of files see Additional file 1: Table S1. Each ChIP-Seq track contributes one feature to our dataset – mean signal over considered region (e.g. enhancer).
Training and performance of classifiers
We used Python implementation of random forest from scikit-learn version 0.14.1. We trained initial classifiers with 100 and 1000 trees. Results in terms of AUC were very similar (improvement by 0.02 to 0.16 points between 100 and 1000 trees), so in favor of time we decided to use 100-trees classifier. We used Gini criterion for split quality (default), as well as other default options, which for example ensures building trees that split training samples perfectly.
Each training was performed with positive and negative training sets of equal sizes. If necessary, when positive and negative sets had different size, subset of samples is drawn from larger set before training.
For performance assessment we used stratified 10-fold cross-validation and computed Area Under Receiver-Operator Characteristic Curve (AUC). Presented values are mean AUC from 10 rounds of training (with, when necessary, independently drawn subsets of our training sets).
P-value of difference of AUC between two classifiers trained on same training set (but different features) is computed as presented in , i.e. it is the p-value (two tailed) for a z-score of tested AUC against expected AUC.
We run Boruta algorithm (, version 3.1), a wrapper around Random Forest, that allows assessment of feature importance comparing to random features. It runs multiple rounds of classification (here up to 100) and compares importance of each feature (defined as Z-score of loss of accuracy if feature is permuted), with importance of random features (shuffled initial features). Features that where significantly (p-value 0.01, Bonferroni correction), more often more important that best random feature are marked as Important, more often less important that best random feature are marked as Unimportant, and after all of rounds the rest is marked as Tentative.
To compute whole-genome predictions we divided hg19 genome (all autosomal chromosomes) into windows of length 1500 bp, every 750 bp. We excluded windows with ambiguous sequence (i.e. containing at least one ‘N’). For each window we output probability of being enhancer – a result of Random Forest voting (as fraction of trees that predict a sequence is active).
Comparison with DNase hypersensitivity sites
To compare enhancers predictions with DNase hypersensitivity sites we downloaded DNase clusters data (V3) from ENCODE database (https://genome.ucsc.edu/ENCODE/) and DNAse ChIP-Seq data from Roadmap Epigenomics database (http://www.roadmapepigenomics.org/). We compare non-specific 4-mers classifier’s predictions on DHS windows (overlapping DHS clusters by at least 100 bp) with non-DHS windows (other). We excluded windows containing TSS and plot results for 1000 randomly selected DHS and non-DHS windows from the 1-st chromosome.
To define tissue-specific DHS and non-DHS windows we use DNAse ChIP-Seq signal. One thousand windows with highest aggregate signal create DHS set, non-DHS set of 1000 windows is drawn randomly from all windows with maximal signal smaller than 10. We compared distribution of prediction for those sets.
Promoter predictions and two-step classifiers
We define promoter predictions as those windows from whole-genome 4-mers predictions that have high score (>0.8) and contain at least one TSS from the list of 215,881 TSS from ENSEMBL (downloaded on July 1, 2015). Classifiers trained on promoter predictions are trained on 50 (out of 1775) heart and 50 (out of 632) randomly chosen brain predicted promoters. Second-step classifiers trained on random or VISTA sequences use sequences with length adjusted (extended or shrunken) to 1500 bp, but maintaining same middle position.
Validation of predictions on new VISTA sequences
After initial training of the classifiers on VISTA sequences few more records were deposited to this database (5 heart and 3 brain enhancers, as of October 10th, 2016). We took the opportunity to validate our classifier on those sequences (see Additional file 1: Table S7). While heart 4-mers classifier predictions were distinguishing heart from brain enhancers (average predictions 0.64 and 0.49), and two-step heart classifier rated heart sequences only slightly above brain (0.3 and 0.27), brain one-step classifier distinguished brain from heart sequences worse (avg. 0.78 and 0.71) than two-step approach (0.52 to 0.33).
Predicting mammalian enhancers using random forest classifier
As our training set we use experimentally validated active enhancers (as positive examples) and random genomic sequences (as a negative set). We took enhancers from VISTA Enhancer Browser , database that contains over thousand of human and mouse sequences tested in transgenic mice, with activity confirmed on particular moment of embryonic development. VISTA sequences are also annotated with tissue (or tissues) of activity. For tissue-specific prediction we chose heart and brain tissue, since these where the most abundant in our active enhancers database, and for non-specific we use both heart and brain active sequences.
Adding histone modifications data to sequence information improves prediction
AUC obtained by different classifiers (mean from 10 rounds of training under 10-fold crossvalidation)
Histone modifications data came from ENCODE project (). We used all available at the time ChIP-Seq tracks for histone modifications in the most well studied cell types – cells in Tier 1 (defined by ENCODE as most important to their research cell types) and non-cancer cells from Tier 2 (group with second importance) available at the moment. We will refer to that set as Tier1&2. We also performed training for subset of described data – histone modification only from embryonic stem cells (H1hESC) to see how much of the information from the extensive ENCODE dataset can be extracted from the ground state of the Embryonic stem cells. See list of all used data in Additional file 1: Table S1.
Great advantage of Random Forest classifiers over SVM methods is the ability to easily analyse their structure and measure the importance of individual features, e.g. single 4-mers. To do that, we used Boruta algorithm (), a wrapper around Random Forest, that runs classification multiple times and compares feature importance defined as loss of accuracy if feature is permuted, with importance of random features (shuffled initial features). It labels features that are significantly more important than the best random feature as ‘Confirmed’, and rejects the features that are less important than best random. The features that do not meet either of the criteria are labeled ‘Tentative’.
Using Boruta algorithm we found features important for 4 mers+Tier1&2 classifier for heart and brain (see summary in Fig. 2 b, full data in Additional file 1: Table S2). Both types of attributes (sequence and histone modification) were found among important ones: most of histone modifications from H1hESC, some histone modifications from HUVEC and other cell types, and almost one-third of 4-mers. While almost all of the ESC histone features were important for both heart and brain, majority of non-ESC modifications were only predictive in specific tissues. The k-mers were also much more specific in their relevance.
This is consistent with the view that the basic enhancer markers such as H3K4me1 are actually already deposited on enhancers very early in the stem cell stage and the later modifications of these marks are not adding more information for the classifier. However, the early marks may be helpful in finding the negative examples of sequences with the right features, which are positioned in the chromatin context not allowing them to be activated and therefore not marked epigenetically already in the ESC stage. This is consistent with previous reports we found in Drosophila developmental enhancers .
Whole-genome predictions correlate with DHS
Activity of an enhancer is dependent on (among other factors) accessibility of DNA in the region where it is located. DNaseI digestion is one of the main methods used to evaluate this property . Using such measurements, allows us to test our prediction quality on a technically independent experimental dataset, as well as to test (at least to some extent) the true negative predictive value (this is not possible on the randomized training set as we are not sure how many of the random sequences are indeed non-functional. We expect that active enhancers will all be located in open chromatin, although enhancers will consist only part of all DNaseI hypersensitive regions.
We used our classifiers to compute predictions on the whole human genome, divided into overlapping windows of length 1500 bp. We compared values returned by our 4-mers classifiers for windows overlapping DNase Hypersensitive Sites (DHS) and windows without hypersensitivity (non-DHS) (see Fig. 2 c and d). For general set of DHS from the ENCODE , derived from multiple cell-lines and not specific to heart or brain, the classifiers results for DHS were slightly, but significantly above results for non-DHS (Mann-Whitney tests p-value <10−4). Situation was different with fetal heart and brain DNase data from the Epigenomics Roadmap project – our classifier returned clearly higher rates for DHS in compare to specific-non-DHS (p-values <10−130).
Tissue-specificity of predictions is low
This result is in agreement with the previous reports by Erwin et al., who also noticed significant overlaps in genome wide predictions made by classifiers trained on data from different tissues. While their approach is to use direct machine learning to discern between the known classes of enhancers, we have gone a different route and tried to find a more direct explanation for this problem and a slightly different solution.
Whole-genome predictions show promoter-bias
This is in contrast with our set of random training sequences where promoter proximal sequences amounted to less than 10% (9% of random sequences for heart classifier and 7% of sequences for brain classifier). This is a significant enrichment (binomial test p-value <10−250). Region of 1500 bases upstream of TSS should contain promoter sequences and many promoter-related transcription factor binding sites, and this promoter-related signal seems to be picked up by the machine learning algorithm leading to a non-specific bias. This problem is not only affecting our method — it is also an issue in EnhancerFinder , for which 23% of heart predictions and 16% of brain predictions are TSS-proximal (p-value <10−100). It is related to the fact that the training sets, especially heart-specific sequences are slightly enriched in regions overlapping promoters (17% for heart, 9% for brain, p-values 0.03 and 0.08), however the machine-learning predictions are yet significantly enriched with TSS-proximal regions over the positive examples (p-value <10−80).
Although promoters are well annotated, so TSS-close predictions can easily be filtered out, we were interested whether we could train our model to discern between enhancers and promoters. If successful, this could help us in the task of predicting tissue-specific enhancer predictors that are not dependent on the knowledge of the “unwanted” enhancer classes, but rather leverage the removal of the promoter bias.
Two-step classifiers improve specificity
Our first approach was to add enhancers vs. promoters classifiers. As a negative training set we used promoter-containing windows selected by our first-level 4-mers classifiers (heart and brain) with prediction over 0.8. As a positive set we used our previous set of heart and brain enhancers, after adjusting lengths of this sequences to our window length, and removing regions containing TSS. While we were able to discern the enhancers from promoters (AUC = 84%), it proved to be unusable for our purposes as still mixed the promoter and enhancer signatures into a single model. That resulted in the situation, where many random sequences were rated high because of their dissimilarity to the set of promoter sequences (See Fig. 4 b).
For this reason we have turned to training our second classifier on promoter vs. randomly selected sequences. Here we consider random sequences (of length 1500) the positive training set, and promoter windows the negative set. We combine two classifiers by multiplying their predictions, where a high score can be achieved only if the sequence has similar features to the enhancers from the positive set of the first classifier and dissimilar to the promoters of the second classifier. This multiplication of scores leads to slight decrease of the model performance (e.g. AUC from 0.91 to 0.82 for the brain) likely because some of the enhancers indeed include promoter-like features and are likely to be not specific to only one tissue. Nonetheless, we then show that two-step classifiers for both heart and brain indeed show specificity in their prediction against the other class (See Fig. 4 c, d). This is, importantly, despite the fact that the second classifier is not built to specifically exclude the other known tissue, but rather to exclude the non-specific promoter signal.
Discussion and conclusion
Computational predictions of tissue-specific enhancer activity based on the sequence and epigenetic features is an important field of research, given the complexity of metazoan organisms and the difficulty of obtaining comprehensive experimental measurements of such activity.
Given the current wealth of experimental data, this problem can be formulated as a supervised machine learning task with the positive set taken from an experimental dataset such as the Vista database and the negative set usually taken from a controlled randomized set of genomic sequences.
In our paper, we describe a new approach that uses random forests for this classification task. It has several advantages over the previous studies in this area. In particular, we were able to assess the relative utility of different histone modifications as well as different sequence features for prediction of active enhancers in different tissues.
This allowed us to define a greatly reduced set of features including only histone modifications from the embryonic stem cells (8 ChIP-Seq experiments) and k-mers to achieve over 90 percent AUC score.
Using the Boruta package, we were also able to verify which sequence features were the most important and see that the data we have are consistent with the hypothesis that the tissue-specific activity of an enhancer is a combined result of the epigenetic context laid out early in the development and the sequence specific binding of the transcription factors expressed in a given tissue.
We have assessed the genome-wide specificity of such classifiers on the brain and heart related datasets from the Vista database and found that while there is a detectable difference between the positive sequence sets for different tissues, both classifiers are ranking the positive sequences from a different tissue significantly better than the control sequences. This is in agreement with our comparisons with the DNAse-seq data, which point to the same conclusion of the predictions being specific only in comparison with negative controls, but not between classifiers trained on different positive sets.
We found that at least part of this problem is related to the fact that such classifiers are prone to “learning” the enrichment of enhancer-proximal sequences in the positive training sets. This leads to great over-representation of promoter sequences in the predictions of both our classifier as well as the previously published methods.
To find out whether the cause of this observation can be the actual set of sequence features contained in promoter-proximal sequences we have tried to construct a classifier based on purely sequence features that would discern promoters from a control set of sequences. This has proven to be possible and indeed we have further shown that combined classifier using both the promoter related features and the enhancer-trained classifier, is resulting in a much greater specificity between tissues.
We consider our results promising, in the sense that they bring a finer understanding of the mechanisms behind tissue-specific enhancer activity while giving us at the same time useful classifiers and genome-wide predictions. Simultaneously, our results bring new questions into the field. In particular, of our results are correct, we should pay much more attention to the mechanistic difference between enhancers and promoters when building computational methods of analysis and detection of regulatory sequences.
In the long term, these results can lead to better understanding of how mutations in regulatory sequences can disrupt enhancer or promoter function and allow us to better understand the root causes of some genetic diseases.
Publication of this article has been funded by Polish National Science Center grant number DEC-2014/12/W/NZ1/00463. This work was partially supported by the Polish National Science Center grants with decision numbers DEC-2012/05/B/NZ2/00567 and DEC-2014/12/W/NZ1/00463.
Availability of data and materials
BW and JHI have prepared data, trained all classifiers and prepared manuscript. BW and MW have analyzed predictions in context of DHS sites and created website providing predictions. All authors read and agreed upon the final version of the manuscript.
The authors declare that they have no competing interests.
Consent for publication
Ethics approval and consent to participate
About this supplement
This article has been published as part of BMC Medical Genomics Volume 10 Supplement 1, 2017: Selected articles from the 6th Translational Bioinformatics Conference (TBC 2016): medical genomics. The full contents of the supplement are available online at https://bmcmedgenomics.biomedcentral.com/articles/supplements/volume-10-supplement-1.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Marsman J, Horsfield JA. Long distance relationships: enhancer–promoter communication and dynamic gene transcription. Biochim Biophys Acta (BBA) - Gene Regul Mech. 2012; 1819(11–12):1217–27. doi:10.1016/j.bbagrm.2012.10.008.View ArticleGoogle Scholar
- Wilczynski B, Furlong EEM. Challenges for modeling global gene regulatory networks during development: insights from Drosophila. Dev Biol. 2010; 340(2):161–9. doi:10.1016/j.ydbio.2009.10.032.. Accessed 29 Mar 2016View ArticlePubMedGoogle Scholar
- Gallo SM, Gerrard DT, Miner D, Simich M, Des Soye B, Bergman CM, Halfon MS. REDfly v3.0: toward a comprehensive database of transcriptional regulatory elements in Drosophila. Nucleic Acids Res. 2011; 39(Database issue):118–23. doi:10.1093/nar/gkq999. Accessed 5 Jan 2011View ArticleGoogle Scholar
- Kvon EZ, Kazmar T, Stampfel G, Yanez-Cuna JO, Pagani M, Schernhuber K, Dickson BJ, Stark A. Genome-scale functional characterization of Drosophila developmental enhancers in vivo. Nat Adv Online Publ. 2014. doi:10.1038/nature13395. Accessed 27 June 2014
- Kundaje A, Meuleman W, Ernst J, Bilenky M, Yen A, Heravi-Moussavi A, Kheradpour P, Zhang Z, Wang J, Ziller MJ, et al. Integrative analysis of 111 reference human epigenomes. Nature. 2015; 518(7539):317–30.View ArticlePubMedPubMed CentralGoogle Scholar
- Krivan W, Wasserman WW. A predictive model for regulatory sequences directing liver-specific transcription. Genome Res. 2001; 11(9):1559. doi:10.1101/gr.180601. Accessed 13 May 2009View ArticlePubMedPubMed CentralGoogle Scholar
- Wasserman WW, Fickett JW. Identification of regulatory regions which confer muscle-specific gene expression. J Mol Biol. 1998; 278(1):167–81. doi:10.1006/jmbi.1998.1700. Accessed 13 May 2009View ArticlePubMedGoogle Scholar
- Berman BP, Nibu Y, Pfeiffer BD, Tomancak P, Celniker SE, Levine M, Rubin GM, Eisen MB. Exploiting transcription factor binding site clustering to identify cis-regulatory modules involved in pattern formation in the Drosophila genome. Proc Natl Acad Sci USA. 2002; 99(2):757. doi:10.1073/pnas.231608898. Accessed 12 Mar 2010View ArticlePubMedPubMed CentralGoogle Scholar
- Hallikas O, Palin K, Sinjushina N, Rautiainen R, Partanen J, Ukkonen E, Taipale J. Genome-wide prediction of mammalian enhancers based on analysis of transcription-factor binding affinity. Cell. 2006; 124(1):47–59.View ArticlePubMedGoogle Scholar
- Wilczynski B, Dojer N, Patelak M, Tiuryn J. Finding evolutionarily conserved cis-regulatory modules with a universal set of motifs. BMC Bioinforma. 2009; 10(1):82.View ArticleGoogle Scholar
- Arunachalam M, Jayasurya K, Tomancak P, Ohler U. An alignment-free method to identify candidate orthologous enhancers in multiple drosophila genomes. Bioinformatics. 2010; 26(17):2109–15.View ArticlePubMedPubMed CentralGoogle Scholar
- Kleftogiannis D, Kalnis P, Bajic VB. Progress and challenges in bioinformatics approaches for enhancer identification. Brief Bioinform. 2015; 101. doi:10.1093/bib/bbv101. Accessed 19 Jan 2016
- Wilczynski B, Tiuryn J. Fastbill: An improved tool for prediction of cis-regulatory modules. J Comput Biol. 2017; 24(3):193–9. doi:10.1089/cmb.2016.0108. https://www.ncbi.nlm.nih.gov/pubmed/27710048.View ArticlePubMedGoogle Scholar
- Dabrowski M, Dojer N, Krystkowiak I, Kaminska B, Wilczynski B. Optimally choosing pwm motif databases and sequence scanning approaches based on chip-seq data. BMC Bioinforma. 2015; 16(1):1.View ArticleGoogle Scholar
- Kazemian M, Zhu Q, Halfon MS, Sinha S. Improved accuracy of supervised crm discovery with interpolated markov models and cross-species comparison. Nucleic Acids Res. 2011; 39(22):9463–72. doi:10.1093/nar/gkr621. https://www.ncbi.nlm.nih.gov/pubmed/21821659.View ArticlePubMedPubMed CentralGoogle Scholar
- Szalkowski AM, Schmid CD. Rapid innovation in chip-seq peak-calling algorithms is outdistancing benchmarking efforts. Brief Bioinform. 2011; 12(6):626–33.View ArticlePubMedGoogle Scholar
- Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, Barrera LO, Van Calcar S, Qu C, Ching KA, et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet. 2007; 39(3):311–8.View ArticlePubMedGoogle Scholar
- Bonn S, Zinzen RP, Girardot C, Gustafson EH, Perez-Gonzalez A, Delhomme N, Ghavi-Helm Y, Wilczynski B, Riddell A, Furlong EEM. Tissue-specific analysis of chromatin state identifies temporal signatures of enhancer activity during embryonic development. Nat Genet. 2012; 44(2). doi:10.1038/ng.1064. Accessed 10 Jan 2012
- Wilczynski B, Furlong EEM. Dynamic CRM occupancy reflects a temporal map of developmental progression. Mol Syst Biol. 2010; 6. doi:10.1038/msb.2010.35. Accessed 22 July 2010
- Thomas S, Li XY, Sabo PJ, Sandstrom R, Thurman RE, Canfield TK, Giste E, Fisher W, Hammonds A, Celniker SE, Biggin MD, Stamatoyannopoulos JA. Dynamic reprogramming of chromatin accessibility during Drosophila embryo development. Genome Biol. 2011; 12(5):43. doi:10.1186/gb-2011-12-5-r43. Accessed 2011-08-12View ArticleGoogle Scholar
- Mercer TR, Edwards SL, Clark MB, Neph SJ, Wang H, Stergachis AB, John S, Sandstrom R, Li G, Sandhu KS, Ruan Y, Nielsen LK, Mattick JS, Stamatoyannopoulos JA. DNase I-hypersensitive exons colocalize with promoters and distal regulatory elements. Nat Genet. 2013; 45. doi:10.1038/ng.2677. Accessed 26 June 2013
- Erwin GD, Oksenberg N, Truty RM, Kostka D, Murphy KK, Ahituv N, Pollard KS, Capra JA. Integrating diverse datasets improves developmental enhancer prediction. PLoS Comput Biol. 2014; 10(6):1003677. doi:10.1371/journal.pcbi.1003677.View ArticleGoogle Scholar
- Fletez-Brant C, Lee D, McCallion AS, Beer MA. kmer-SVM: a web server for identifying predictive regulatory sequence features in genomic data sets. Nucleic Acids Res. 2013; 41(W1):544–56. doi:10.1093/nar/gkt519. Accessed 16 Sept 2013View ArticleGoogle Scholar
- Podsiadło A, Wrzesień M, Paja W, Rudnicki W, Wilczyński B. Active enhancer positions can be accurately predicted from chromatin marks and collective sequence motif data. BMC Syst Biol. 2013; 7(Suppl 6):16.View ArticleGoogle Scholar
- Rajagopal N, Xie W, Li Y, Wagner U, Wang W, Stamatoyannopoulos J, Ernst J, Kellis M, Ren B. Rfecs: a random-forest based algorithm for enhancer identification from chromatin state. PLoS Comput Biol. 2013; 9(3):1002968.View ArticleGoogle Scholar
- Firpi HA, Ucar D, Tan K. Discover regulatory dna elements using chromatin signatures and artificial neural network. Bioinformatics. 2010; 26(13):1579–86.View ArticlePubMedPubMed CentralGoogle Scholar
- Danko CG, Hyland SL, Core LJ, Martins AL, Waters CT, Lee HW, Cheung VG, Kraus WL, Lis JT, Siepel A. Identification of active transcriptional regulatory elements from gro-seq data. Nat Methods. 2015; 12(5):433–8.View ArticlePubMedPubMed CentralGoogle Scholar
- Zhu Y, Sun L, Chen Z, Whitaker JW, Wang T, Wang W. Predicting enhancer transcription and activity from chromatin modifications. Nucleic Acids Res. 2013; 41(22):10032–43.View ArticlePubMedPubMed CentralGoogle Scholar
- Bednarz P, Wilczyński B. Supervised learning method for predicting chromatin boundary associated insulator elements. J Bioinforma Comput Biol. 2014; 12(06):1442006.View ArticleGoogle Scholar
- Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983; 148(3):839–43.View ArticlePubMedGoogle Scholar
- Kursa MB, Rudnicki WR. Feature selection with the Boruta package. J Stat Softw. 2010; 36(11):1–13.View ArticleGoogle Scholar
- Breiman L. Random forests. Mach Learn. 2001; 45(1):5–32. doi:10.1023/A:1010933404324.View ArticleGoogle Scholar
- Visel A, Minovitsky S, Dubchak I, Pennacchio LA. VISTA Enhancer Browser–a database of tissue-specific human enhancers. Nucleic Acids Res. 2007; 35(Database issue):88–92.View ArticleGoogle Scholar
- Bernstein BE, Birney E, et all D. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012; 489(7414):57–74.View ArticleGoogle Scholar